| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tango Therapeutics, Inc. | Director | Common Stock | 20,937 | $23,868 | $1.14 | 05 Jun 2025 | Direct |
| Tango Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 37,500 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | 05 Jun 2025 | 2 | $0 | 4 | Director | 09 Jun 2025, 17:47 |
| TNGX | Tango Therapeutics, Inc. | 05 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 17:13 |
| TNGX | Tango Therapeutics, Inc. | 29 Aug 2023 | 2 | $0 | 4 | Director | 31 Aug 2023, 16:07 |
| TNGX | Tango Therapeutics, Inc. | 29 Aug 2023 | 0 | $0 | 3 | Director | 31 Aug 2023, 16:05 |